Literature DB >> 14745050

Ophthalmologic features of Parkinson's disease.

V Biousse1, B C Skibell, R L Watts, D N Loupe, C Drews-Botsch, N J Newman.   

Abstract

Patients with Parkinson's disease (PD) commonly complain of impaired visual function and difficulty reading, despite normal visual acuity. Although previous studies have evaluated contrast sensitivity, color vision, visuospatial processing, visual hallucinations, and ocular movements, none has systematically evaluated the ocular complaints and ocular findings of PD patients. Thirty patients with early untreated PD and 31 control subjects without neurologic or known ocular diseases were ophthalmologically evaluated for the frequency of visual complaints, dry eyes, blepharitis, visual hallucinations, reduced blink rate, blepharospasm, and convergence insufficiency. Ocular complaints suggesting ocular surface irritation, altered tear film, visual hallucinations, blepharospasm, decreased blink rate, and decreased convergence amplitudes were more common in PD patients than in control subjects. These findings likely account for many of the visual difficulties commonly encountered by PD patients. These ocular abnormalities frequently respond to treatment.

Entities:  

Mesh:

Year:  2004        PMID: 14745050     DOI: 10.1212/01.wnl.0000103444.45882.d8

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  54 in total

1.  Case-control study of blink rate in Parkinson's disease under different conditions.

Authors:  Emily Fitzpatrick; Norman Hohl; Peter Silburn; Cullen O'Gorman; Simon A Broadley
Journal:  J Neurol       Date:  2011-10-08       Impact factor: 4.849

2.  Ocular motor and sensory function in Parkinson's disease.

Authors:  Zina Almer; Kathyrn S Klein; Laura Marsh; Melissa Gerstenhaber; Michael X Repka
Journal:  Ophthalmology       Date:  2011-09-29       Impact factor: 12.079

3.  Improvement of lateral axial dystonia following prismatic correction of oculomotor control disorders in Parkinson's disease.

Authors:  Marco Santilli; Michele Meglio; Sara Varanese; Francesco Lena; Ennio Iezzi; Giovanni Grillea; Nicola Modugno
Journal:  J Neurol       Date:  2016-01-11       Impact factor: 4.849

4.  Cases: Charles Bonnet syndrome: visual loss and hallucinations.

Authors:  M L Jackson; Joseph Ferencz
Journal:  CMAJ       Date:  2009-08-04       Impact factor: 8.262

5.  Disease-related and genetic correlates of psychotic symptoms in Parkinson's disease.

Authors:  Stewart A Factor; N Kyle Steenland; Donald S Higgins; Eric S Molho; Denise M Kay; Jennifer Montimurro; Ami R Rosen; Cyrus P Zabetian; Haydeh Payami
Journal:  Mov Disord       Date:  2011-06-28       Impact factor: 10.338

Review 6.  Vergence Neural Pathways: A Systematic Narrative Literature Review.

Authors:  Annabelle Searle; Fiona J Rowe
Journal:  Neuroophthalmology       Date:  2016-09-02

Review 7.  Disorders of Vergence Eye Movements.

Authors:  Anthony J Brune; Eric R Eggenberger
Journal:  Curr Treat Options Neurol       Date:  2018-08-23       Impact factor: 3.598

8.  Evaluation of corneal parameters in patients with Parkinson's disease.

Authors:  Seden Demirci; Alime Gunes; Hasan Rifat Koyuncuoglu; Levent Tok; Ozlem Tok
Journal:  Neurol Sci       Date:  2016-04-07       Impact factor: 3.307

Review 9.  Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease.

Authors:  Fanni F Geibl; Martin T Henrich; Wolfgang H Oertel
Journal:  J Neural Transm (Vienna)       Date:  2019-01-14       Impact factor: 3.575

10.  Investigating the mechanisms of hallucinogen-induced visions using 3,4-methylenedioxyamphetamine (MDA): a randomized controlled trial in humans.

Authors:  Matthew J Baggott; Jennifer D Siegrist; Gantt P Galloway; Lynn C Robertson; Jeremy R Coyle; John E Mendelson
Journal:  PLoS One       Date:  2010-12-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.